AbBC Therapies
Phase 1AbBC Therapies is a next generation ADC and immunotoxin company that utilizes a biological conjugation process to target and deliver Granzyme B to cells
Founded
2020
Focus
AntibodiesBiologics
About
AbBC Therapies is a next generation ADC and immunotoxin company that utilizes a biological conjugation process to target and deliver Granzyme B to cells
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile